Daryl L. Thompson
Daryl L. Thompson is an American inventor and entrepreneur whose work focuses on pharmaceutical and biological research. His work has been published[1] and cited[2] in the scientific community and he has been granted 7 US patents.[3]
Life and career
Since 2010, Thompson has served as President and Director of Scientific Initiatives at Global Research and Discovery Group (GRDG Sciences, LLC) in Winter Haven, FL, which is a private research and development organization. GRDG Sciences is a think tank that works to provide solutions to emerging global epidemics. Upon problem assessment, GRDG immediately identifies and recruits leading research personnel in each required discipline from an established global network to efficiently execute custom research directives to produce real-time and effective solutions.[4] Some recent projects are:
- Linebacker - multi-faceted therapeutic platform for metabolic, neurologic, cancer, and infectious diseases[4]
- 3F Functional Fragrance Technology for mosquito avoidance and antimicrobial protecting including recent results confirming effectiveness against Tuberculosis. This technology is designed to be incorporated into the Open Air Defense Initiative for protection against outbreaks by protecting key points where the potential spread of pathogens occur.[4]
- Sweet Sense Sugar - a low Glycemic Index sugar[5]
- Pandemic Response Strategies and Technology - including Equivir/Nemovir, a patented therapeutic successfully tested against Rhinovirus, Influenza, Cholera and in a Biosafety Level 4 facility, Ebola.
- Quantum - the solution to the Patent Cliff[6] accomplished by applying quantum mechanics to drug discovery.
GRDG works outside of government institutions and is exclusively focused on developing medical countermeasures that adhere to the principles and initiatives established by Project Bioshield, BARDA, and the Potomac Institute for Policy Studies.
Thompson is Director of Scientific Initiatives and a member of the Board of Directors of Global BioLife, Inc.,[7] a partnership formed to develop and commercialize some of the GRDGS technology, which includes former Assistant Surgeon General of the United States Dr. Roscoe M. Moore, Jr. as Senior Scientific Adviser, and former U.S. Army Medical Service Corps Officer LTC (Ret) William H. Lyerly Jr. [8]
Thompson was previously President of ATM Metabolics, LLC which specializes in the development of phyto-chemical pharmaceuticals aimed at preventing and reversing metabolic and neurological diseases.
Thompson was a founder, partner, and served as senior vice president and director of research at Solution Health Systems, Boca Raton, FL, from 2003 to 2006. During that time, his research focused on metabolic issues to solve the global diabetes epidemic.
In 2000, Thompson was recognized for designing a non-invasive glucose meter and received the Diabetes World Humanitarian Award from the Diabetes Research Center.
Published Scientific Studies
Thompson is co-author of two published scientific studies:
- Effect of Emulin on Blood Glucose in Type 2 Diabetics [9][1]
- Myricetin derivatives ameliorate deficits in 6-OHDA animal model of Parkinson's disease [10][11]
Inventions and Patents
Thompson has successfully developed, patented, and/or marketed:
- Method and composition for preventing and treating viral infections, US Patent #10,383,842[12]
- Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders, US Patent #10,123,991[13]
- Composition and method for the treatment of neurological disorders, US Patent #8,034,838[14]
- Composition and method for treating diabetes and metabolic disorders, US Patent #8,198,319[15]
- Composition and method for treating diabetes and metabolic disorders, US Patent #7,943,164[16]
- Composition and method for inhibiting reverse transcript of a retrovirus, US Patent #6,319,711[17]
- Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent, US Patent #6,090,602[18]
- Method and composition for crude formulations of fortified sugar for glycemic control, US Patent Application #15/808117[19]
- Low Glycemic Sugar Composition, US Patent Application #15/698159[20]
- A non-invasive blood glucose measuring device
- The Grapefruit Solution, a grapefruit-based compound which provides clinically documented weight loss without a change in diet or exercise.
- A natural-based food supplement and pharmaceutical that buffers the sugar in foods and drinks to make foods safer for diabetics and healthier for the population at large.
Books
The Grapefruit Solution: Lower Your Cholesterol, Lose Weight and Achieve Optimal Health with Nature’s Wonder Fruit (LINX Corp., 2004), with M. Joseph Ahrens [21]
References
- ^ a b [1] Google Scholar List of Emulin study versions
- ^ [2] Google Scholar Citations of Daryl L. Thompson
- ^ [3] USPTO List of Daryl Thompson Patents
- ^ a b c [4] GlobalRDG.com
- ^ [5] SweetSenseSugar.com
- ^ [6] Patent Cliff
- ^ [7] GlobalBioLife.com
- ^ [8] BioSpace article on Global BioLife
- ^ [9] Journal of Medicinal FoodVol. 16, No. 3
- ^ [10] Charles River Presentations
- ^ [11] Neuroscience 2018 Presentations
- ^ [12] US Patent #10,383,842
- ^ [13] US Patent #10,123,991
- ^ [14] US Patent #8,034,838
- ^ [15] US Patent #8,198,319
- ^ [16] US Patent #7,943,164
- ^ [17] US Patent #6,319,711
- ^ [18] US Patent #6,090,602
- ^ [19] US Patent Application #15/808117
- ^ [20] US Patent Application 15/698159
- ^ [21] The Grapefruit Solution